Current Process Chemistry: Successes and Challenges in Drug Substance Process R&D

The focus of this meeting will be case studies of successful routes of synthesis for drug substance/API. But the overarching theme will be how process chemists deal with the challenge of ‘fit for purpose’ process R&D. Can you have a process that is workable for early phase or pre-clinical supply demands that have short timelines while at the same time planning for more long term development strategies?  Click here to view a list of past Process Chemistry participants 

Session Include: 

• Case Studies of API Scale-up: Part I
• Chemistry through CROs
• Process Improvements
• Breakout Roundtable Discussions
• Clean and Green via Strategic Route Design
• Biocatalysis, Continuous Processing and Case Studies: Part II

Keynote Speaker 

Michael J. Krische, Ph.D., Chair, Department of Chemistry and Biochemistry and Director, Center for Green Chemistry and Catalysis, University of Texas at Austin




 

Pre-conference Short Course* 

June 1, 2011 

Development of APIs — Efficiencies for a New Decade 

Course Instructor: Neal G. Anderson, Principal, Anderson’s Process Solutions

*Separate registration required

Featured Speakers 

Scott M. Duncan, Ph.D., Senior Manager, API Development & Process Chemistry, Alkermes, Inc.





 

Mahavir Prashad, Ph.D., Head of Chemical Development Unit US. Novartis Pharmaceuticals Corporation





 

Bruce Ross, Ph.D., Director, Process Research, Pharmasset






 

Matthew Truppo, Ph.D., Senior Scientist, Process Chemistry, Merck





 

Who should attend: 

• Scientists, Chemists, and Chemical Engineers working in departments related to drug substance process development such as:
• Chemistry Process R&D
• Chemical Development
• Chemical Process Development
• Pharmaceutical Develompent
• Pharmaeutical Chemical Engineering
• Process Research
• Process Chemistry
• Process R&D